Results 191 to 200 of about 21,337,282 (283)
Time analysis of hospital costs for respiratory diseases in Brazil, 1998-2021. [PDF]
Santos MLBA +5 more
europepmc +1 more source
2008 annual report - National Center for Immunization and Respiratory Diseases
"The National Center for Immunization and Respiratory Diseases is completing its second year with a renewed commitment to make a difference. Thanks to the hard work of CDC staff and partners, our collective efforts are paying off. Immunization Action: To
core
A Monolithic Janus Hydrogel Pressure Sensor for Wearable Motion and Physiological Monitoring
This work reports a monolithic Janus hydrogel pressure sensor featuring integrated conductive PEDOT and insulating PEGDA layers. The fabricated device achieves a rapid response time, a wide operating range, and good cyclic durability. The sensor demonstrates robust performance in tracking dynamic human joint motions, offering a scalable strategy for ...
Syed Atif Ali +7 more
wiley +1 more source
Analysis of Spatiotemporal Risks of Environmental Driving Factors of Respiratory Diseases. [PDF]
Yang X, Wang J, Zhang G, Yu Z.
europepmc +1 more source
Artificial Intelligence‐Guided Phenotypic Drug Repurposing Against Streptococcus pneumoniae
Integrated artificial intelligence (AI) ensembles identify highly potent repurposed drugs against Streptococcus pneumoniae. Prospective virtual screening of 6747 drugs uncovers nine active candidates, including thiostrepton. This drug exhibits low picomolar potency and bypasses established resistance in multidrug‐resistant strains, demonstrating an ...
Joshua S. Fitch +6 more
wiley +1 more source
A Comparative Analysis of Aging Across Causes of Death. [PDF]
Sorci G, Faivre B.
europepmc +1 more source
This work identifies acetylation‐dependent SDHA homeostasis as a determinant of tumor‐specific metabolic vulnerability. Guided by this mechanism, a modification‐selective inhibitor, ZPI‐3, selectively targets non‐acetylated SDHA, achieving tumor‐restricted SDH inhibition and effective bladder cancer control. Differential responses in clinical specimens
Kaikai Xu +9 more
wiley +1 more source
Beyond Pathogens: Modulating the Commensal Microbiota to Reshape Immunity for Respiratory Disease Intervention. [PDF]
Yang Y +10 more
europepmc +1 more source
Self‑amplifying PCSK9–LOX‑1 feedback axis drives atherosclerotic progression by promoting oxLDL generation and endothelial uptake. A dual‑targeting nanoplatform (siPCSK9@PEAL NPs‑aL) is constructed to simultaneously silence hepatic PCSK9 for lipid lowering and block plaque LOX‑1 for anti‑inflammation.
Yi Duan +7 more
wiley +1 more source

